1-6 of 6
Franklin Hendrick, B.S.
Close
Sort by
Journal Articles

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis.

Amy J. Davidoff, M.S., Ph.D., Franklin Hendrick, B.S., Bruce C. Stuart, PhD, Amer M. Zeidan, MD, Rahul Shenolikar, PhD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 3176.
https://doi.org/10.1182/blood.V120.21.3176.3176
Published: 2012
Journal Articles

Lenalidomide Performance in the Real World: Patterns of Utilization and Effectiveness in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Steven D. Gore, MD, Diane L. McNally, BSPharm, M.S., Maria R. Baer, M.D., Franklin Hendrick, B.S., Dalia Mahmoud, MBA, Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3837.
https://doi.org/10.1182/blood.V120.21.3837.3837
Published: 2012
Journal Articles

Association Between FDA Safety Warnings, CMS Coverage Restrictions and Adherence to Guidelines for ESA Use in Patients with Myelodysplastic Syndromes

Franklin Hendrick, B.S., Amy J. Davidoff, M.S., Ph.D., Amer M. Zeidan, MD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 971.
https://doi.org/10.1182/blood.V120.21.971.971
Published: 2012
Journal Articles

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Franklin Hendrick, B.S., Erika Friedmann, PhD, Steven D. Gore, MD, Maria R. Baer, M.D., Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 426.
https://doi.org/10.1182/blood.V120.21.426.426
Published: 2012
Journal Articles

Do Erythropoiesis-Stimulating Agents (ESAs) Affect Survival in Anemic Patients with Myelodysplastic Syndromes (MDS)?

Amy J. Davidoff, M.S., Ph.D., Xuehua Ke, M.A., Maria R. Baer, MD, Sheila R Weiss Smith, PhD, Dan Zandberg, MD, Franklin Hendrick, B.S., Masayo Sato, M.S., Peter L. Greenberg, MD, Steven D. Gore, MD
Journal: Blood
Blood (2011) 118 (21): 2794.
https://doi.org/10.1182/blood.V118.21.2794.2794
Published: 2011
Journal Articles

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Amy J. Davidoff, PhD, M.S., Sheila Weiss Smith, PhD, Maria R Baer, M.D., Xuehua Ke, M.A., Jason M Bierenbaum, M.D., Franklin Hendrick, B.S., Diane L. McNally, BSPharm, M.S., Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 3815.
https://doi.org/10.1182/blood.V116.21.3815.3815
Published: 2010